Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3048 |
|
Actual shortage: | 226 (7%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2799 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2018-10-11 | 2018-11-22 | 63800 |
APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2019-05-01 | 2019-06-08 | 82907 |
APO-ONDANSETRON | 8MG | TABLET | Resolved | 2019-06-05 | 2019-11-11 | 85604 |
APO-ONDANSETRON | 8MG | TABLET | Resolved | 2019-08-07 | 2019-11-11 | 91097 |
APO-CANDESARTAN | 8MG | TABLET | Resolved | 2020-04-13 | 2020-10-19 | 111895 |
APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-01-08 | 2021-03-01 | 131163 |
APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-06-18 | 2021-07-21 | 141241 |
APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-09-21 | 2021-10-25 | 145937 |
APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2021-09-24 | 2021-09-27 | 146160 |
APO-ONDANSETRON | 8MG | TABLET | Resolved | 2021-10-08 | 2022-02-28 | 146907 |
APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2021-10-29 | 2021-11-15 | 148539 |
APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-11-12 | 2021-12-20 | 149167 |
APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2022-05-13 | 2022-06-06 | 160604 |
APO-CANDESARTAN | 8MG | TABLET | Actual shortage | 2022-08-12 | 2022-08-12 | 166592 |
APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2022-11-11 | 2022-12-09 | 174347 |
APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2023-06-09 | 2023-10-15 | 194587 |
APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2023-12-15 | 2023-12-22 | 213550 |
APO-DILTIAZ SR | 90MG | CAPSULE (SUSTAINED-RELEASE) | Actual shortage | 2017-08-13 | 2017-10-05 | 19030 |
APO-CINACALCET | 90MG | TABLET | Resolved | 2018-05-08 | 2018-11-23 | 48835 |
APO-DEFERASIROX (TYPE J) | 90MG | TABLET | Resolved | 2020-03-18 | 2020-03-31 | 108930 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 | ||
APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 |